Indo Us Biotech
NSE: INDOUS · ISIN INE250Z01010 · Basic Materials
₹66.55−1.08 (−1.60%)
Monday 9 November, 15:29 IST. Delayed. Source: Yahoo Finance.
Price chart
₹66.55 −1.08 (−1.60%) today
The day
- Previous close
- ₹67.63
- Open
- ₹67.63
- Day high
- ₹68.50
- Day low
- ₹64.15
Listed on NSE since 27 September 2024.
Key numbers
- Market value
- ₹133.45 Cr
- P/E (trailing)
- 11.68
- EPS (trailing)
- ₹5.70
- Price to book
- 1.45
- Dividend yield
- 0.00%
- Debt to equity
- 0.40
- Profit margin
- 10.2%
- Beta
- 0.35
- Volume today
- 4,143
- Average volume
- 18,842
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹61.74 Cr | ₹7.24 Cr |
| FY24 | ₹72.84 Cr | ₹8.24 Cr |
| FY25 | ₹103.84 Cr | ₹16.27 Cr |
| FY26 | ₹110.44 Cr | ₹13.12 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹15 Cr | ₹-4 Cr | −206.4% |
| Q1 FY27Apr–Jun 2026 | ₹33 Cr | ₹3 Cr | −35.4% |
| Q4 FY26Jan–Mar 2026Audited | ₹26 Cr | ₹2 Cr | −46.5% |
| Q3 FY26Oct–Dec 2025 | ₹23 Cr | ₹3 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹31 Cr | ₹3 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹31 Cr | ₹5 Cr | – |
Source: Indo Us Biotech’s results filed with NSE, standalone (the company alone). Net profit is the share of Indo Us Biotech’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹12 Cr | ₹12 Cr |
| Inventories | ₹86 Cr | ₹100 Cr |
| Owed by customers | ₹36 Cr | ₹14 Cr |
| Cash and equivalents | ₹2 Cr | ₹6 Cr |
| Total assets | ₹140 Cr | ₹133 Cr |
| Borrowings | ₹44 Cr | ₹37 Cr |
| Total liabilities | ₹48 Cr | ₹41 Cr |
| Shareholders’ equity | ₹92 Cr | ₹93 Cr |
Source: Indo Us Biotech’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Indo Us Biotech
Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum, mustard, and soyabean seeds. It also provides cumin and isabgul spices seeds; pulses seeds comprising val, gram, black gram, and green gram seeds; and cereals seeds consisting of wheat, maize, bajra, and pegeon pea seeds. It also exports its products. The company was incorporated in 2004 and is based in Ahmedabad, India.
- Industry
- Agricultural Inputs
- Based in
- Ahmedabad
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Indo Us Biotech in the last day or two.
Dividends and corporate actions
All companies- Interim Dividend - Rs 0.25 Per Share
Dividend · ex-date 3 December 2024
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.